|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Product revenues | |||||
| Cost of sales | |||||
| Gross margin | |||||
| Operating expenses: | |||||
| Net research and development expenses | |||||
| Selling, general and administrative expenses | |||||
| Restructuring expenses, net | |||||
| Loss on sale of land and building, net | |||||
| Impairment of intangible assets and property and equipment | |||||
| Impairment of goodwill | |||||
| Total operating expenses | |||||
| Operating income | |||||
| Interest expense, net | |||||
| Foreign currency (loss) gain | |||||
| Other (loss) income | |||||
| Earnings before income tax | |||||
| Income tax expense | |||||
| Net income | |||||
| Basic earnings per share | |||||
| Diluted earnings per share | |||||
| Weighted average number of shares – basic | |||||
| Weighted average number of shares – diluted | |||||
Loading...